Jacek Juszczyk

785 total citations
54 papers, 495 citations indexed

About

Jacek Juszczyk is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Jacek Juszczyk has authored 54 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Epidemiology, 35 papers in Hepatology and 3 papers in Infectious Diseases. Recurrent topics in Jacek Juszczyk's work include Hepatitis C virus research (31 papers), Hepatitis B Virus Studies (28 papers) and Liver Disease Diagnosis and Treatment (20 papers). Jacek Juszczyk is often cited by papers focused on Hepatitis C virus research (31 papers), Hepatitis B Virus Studies (28 papers) and Liver Disease Diagnosis and Treatment (20 papers). Jacek Juszczyk collaborates with scholars based in Poland, United States and Russia. Jacek Juszczyk's co-authors include Krzysztof Simon, Robert Flisiak, Waldemar Halota, Małgorzata Pawłowska, Piotr Małkowski, Krzysztof Tomasiewicz, Andrzej Horban, Jadwiga Jodynis‐Liebert, Anna Boroń‐Kaczmarska and Paweł P. Jagodzińśki and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hepatology and Vaccine.

In The Last Decade

Jacek Juszczyk

52 papers receiving 473 citations

Peers

Jacek Juszczyk

EPIDE

HEPAT

RHEUM

Lydia L. Barlow United States

G.B. Gaeta Italy

Nami Mori Japan

Kung‐Chia Young Taiwan

Jan Maarten Vrolijk Netherlands

Giuseppe Barbaro Italy

D Vetter France

Kenneth Hirsch United States

C. De Bac Italy

S Zeuzem Germany

Lydia L. Barlow United States

Jacek Juszczyk

311 ×0.9

EPIDE

284 ×0.9

HEPAT

43 ×0.7

78 ×1.3

52 ×1.5

RHEUM

Citations per year, relative to Jacek Juszczyk Jacek Juszczyk (= 1×) peers Lydia L. Barlow

Countries citing papers authored by Jacek Juszczyk

Since Specialization

Citations

This map shows the geographic impact of Jacek Juszczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacek Juszczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacek Juszczyk more than expected).

Fields of papers citing papers by Jacek Juszczyk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacek Juszczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacek Juszczyk. The network helps show where Jacek Juszczyk may publish in the future.

Co-authorship network of co-authors of Jacek Juszczyk

This figure shows the co-authorship network connecting the top 25 collaborators of Jacek Juszczyk. A scholar is included among the top collaborators of Jacek Juszczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacek Juszczyk. Jacek Juszczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Flisiak, Robert, Waldemar Halota, Jerzy Jaroszewicz, et al.. (2017). Recommendations for the treatment of hepatitis B in 2017. Clinical and Experimental Hepatology. 2(2). 35–46. 17 indexed citations

Halota, Waldemar, Robert Flisiak, Anna Boroń‐Kaczmarska, et al.. (2015). Recommendations for the treatment of hepatitis C Polish group of HCV Experts--2015.. PubMed. 69(3). 515–31. 4 indexed citations

Flisiak, Robert, Waldemar Halota, Andrzej Horban, et al.. (2011). Prevalence and risk factors of HCV infection in Poland. European Journal of Gastroenterology & Hepatology. 23(12). 1213–1217. 53 indexed citations

Juszczyk, Jacek, Anna Boroń‐Kaczmarska, Janusz Cianciara, et al.. (2010). [Therapeutic recommendations for year 2010: antiviral treatment of chronic HBV infection].. PubMed. 64(1). 81–2. 1 indexed citations

Zabel, M., et al.. (2009). p53 immunocytochemistry and TP53 gene mutations in patients with chronic hepatitis C virus (HCV) infection.. SHILAP Revista de lepidopterología. 1 indexed citations

Kasprzak, Aldona, et al.. (2009). p53 immunocytochemistry and TP53 gene mutations in patients with chronic hepatitis C virus (HCV) infection.. Folia Histochemica et Cytobiologica. 47(1). 35–42. 7 indexed citations

Juszczyk, Jacek, et al.. (2008). Identification of a hepatitis C virus mutant lacking the hypervariable region 1 in a chronically infected patient non-responding to PEG-interferon-α/ribavirin therapy. European Journal of Clinical Microbiology & Infectious Diseases. 28(2). 211–213. 2 indexed citations

Kasprzak, Aldona, et al.. (2007). Intracellular expression of the proliferative marker Ki-67 and viral proteins (NS3, NS5A and C) in chronic, long lasting hepatitis C virus (HCV) infection.. PubMed. 45(4). 357–66. 7 indexed citations

Kruszyna, Łukasz, et al.. (2006). Mutations within protein kinase R-binding domain of NS5A protein of hepatitis C virus (HCV) and specificity of HCV antibodies in pretreatment sera of HCV-chronically infected patients and their effect on the result of treatment.. PubMed. 59(2). 92–9. 13 indexed citations

10.

Podlasin, Regina, Anita Olczak, Marek Beniowski, et al.. (2006). Opportunistic Infections and Other AIDS-defining Illnesses in Poland in 2000–2002. Infection. 34(4). 196–200. 20 indexed citations

11.

Wierzbicki, Andrzej, et al.. (2005). A correlation between the heterogeneity of hypervariable region 1 of E2 glycoprotein of Hepatitis C virus (HCV) and HCV antibody profile: a case study.. PubMed. 49(2). 97–103. 4 indexed citations

12.

Juszczyk, Jacek. (2005). Hepatitis B : to co najważniejsze. Przewodnik Lekarza/Guide for GPs. 7(10). 70–76.

13.

Juszczyk, Jacek, et al.. (2004). [Spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis based on bacteriological and biochemical results].. PubMed. 58(4). 597–607. 3 indexed citations

14.

Juszczyk, Jacek, Beata Bolewska, J Cianciara, et al.. (2000). Combination therapy with interferon alpha-2b and ribavirin in naive patients with chronic hepatitis C. Journal of Hepatology. 32. 199–199. 5 indexed citations

15.

Jagodzińśki, Paweł P., et al.. (2000). Distribution of Δ32 alelle of the CCR5 gene in the population of Poland. Journal of Human Genetics. 45(5). 271–274. 16 indexed citations

16.

Majewska, A.C., et al.. (1999). Kryptosporydioza u osob zakazonych HIV. Wiadomości Parazytologiczne. 45(2). 125–128.

17.

Brojer, Ewa, Piotr Grabarczyk, Joanna Kubicka, et al.. (1999). Anti-HCV RIBA/LiaTek reactivity and HCV genotype in EIA-negative patients with viremia. Journal of Medical Virology. 59(4). 451–455. 2 indexed citations

18.

Majewska, A.C., et al.. (1998). Cryptosporidiosis in HIV-positive patients-first study in Poland. Wiadomości Parazytologiczne. 44(3). 3 indexed citations

19.

Juszczyk, Jacek, et al.. (1997). Reduced glutathione concentration in erythrocytes of patients with acute and chronic viral hepatitis. Journal of Viral Hepatitis. 4(2). 139–141. 76 indexed citations

20.

Brojer, Ewa, et al.. (1996). Hepatitis C Virus Genotypes in Blood Donors and Patients with Chronic Hepatitis C. Vox Sanguinis. 71(1). 51–54. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact